FRX Polymers secures AU$ 15.15 million in pre-IPO mezzanine exchangeable notes

Chelmsford, MA, USA: 4 October 2017 - FRX Polymers Inc, the global leader in polymeric halogen-free flame retardant solutions, announced that it has secured AU$ 15.15 million (approximately US$ 12 million) in pre-IPO mezzanine financing led by a major Chinese Private Equity Fund. Other parties participating in the financing were Brightfield Chemical, an FRX Polymers distributor based in China, and several prominent private equity and hedge funds and family offices located in Australia, Hong Kong, and Southeast Asia.

More info on FRX Polymers' website.


Next > Sequana Medical announces publication of results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T).

Previous > Confo Therapeutics enters into drug discovery collaboration with Lundbeck